Cargando…

The ubiquitin ligase MDM2 sustains STAT5 stability to control T cell-mediated anti-tumor immunity

Detalles Bibliográficos
Autores principales:	Zhou, Jiajia, Kryczek, Ilona, Li, Shasha, Li, Xiong, Aguilar, Angelo, Wei, Shuang, Grove, Sara, Vatan, Linda, Yu, Jiali, Yan, Yijian, Liao, Peng, Lin, Heng, Li, Jing, Li, Gaopeng, Du, Wan, Wang, Weichao, Lang, Xueting, Wang, Weimin, Wang, Shaomeng, Zou, Weiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026726/ https://www.ncbi.nlm.nih.gov/pubmed/33767425 http://dx.doi.org/10.1038/s41590-021-00888-3

Ejemplares similares

LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapy
por: Li, Gaopeng, et al.
Publicado: (2021)

Autophagic adaptation to oxidative stress alters peritoneal residential macrophage survival and ovarian cancer metastasis
por: Xia, Houjun, et al.
Publicado: (2020)

Metabolism drives macrophage heterogeneity in the tumor microenvironment
por: Li, Shasha, et al.
Publicado: (2022)

Ubiquitin ligase Triad1 promotes neurite outgrowth by inhibiting MDM2-mediated ubiquitination of the neuroprotective factor pleiotrophin
por: Wu, Chunshuai, et al.
Publicado: (2022)

MDM2-C Functions as an E3 Ubiquitin Ligase
por: Kim, Jun Yeob, et al.
Publicado: (2020)

DOT1L affects colorectal carcinogenesis via altering T cell subsets and oncogenic pathway
por: Sun, Danfeng, et al.
Publicado: (2022)

Regulation of the MDM2‐p53 pathway by the ubiquitin ligase HERC2
por: García‐Cano, Jesús, et al.
Publicado: (2019)

Small-Molecule Inhibitors of the MDM2–p53 Protein–Protein Interaction (MDM2 Inhibitors) in Clinical Trials for Cancer Treatment: Miniperspective
por: Zhao, Yujun, et al.
Publicado: (2014)

Sorting of a multi-subunit ubiquitin ligase complex in the endolysosome system
por: Yang, Xi, et al.
Publicado: (2018)

Transcriptional repressor NIR interacts with the p53-inhibiting ubiquitin ligase MDM2
por: Heyne, Kristina, et al.
Publicado: (2014)

Tau protein binds to the P53 E3 ubiquitin ligase MDM2
por: Sola, Martina, et al.
Publicado: (2023)

GPCR targeting of E3 ubiquitin ligase MDM2 by inactive β-arrestin
por: Yun, Yaejin, et al.
Publicado: (2023)

The Ubiquitin Ligase TRAF6 Negatively Regulates the JAK-STAT Signaling Pathway by Binding to STAT3 and Mediating Its Ubiquitination
por: Wei, Juncheng, et al.
Publicado: (2012)

Senescence-inducing stress promotes proteolysis of phosphoglycerate mutase via ubiquitin ligase Mdm2
por: Mikawa, Takumi, et al.
Publicado: (2014)

MDM2 E3 ligase-mediated ubiquitination and degradation of HDAC1 in vascular calcification
por: Kwon, Duk-Hwa, et al.
Publicado: (2016)

Decoding the Role of MDM2 as a Potential Ubiquitin E3 Ligase and Identifying the Therapeutic Efficiency of Alkaloids against MDM2 in Combating Glioblastoma
por: Sharma, Sudhanshu, et al.
Publicado: (2023)

Regulatory T cells in the bone marrow microenvironment in patients with prostate cancer
por: Zhao, Ende, et al.
Publicado: (2012)

A conserved RAD6-MDM2 ubiquitin ligase machinery targets histone chaperone ASF1A in tumorigenesis
por: Wang, Chen, et al.
Publicado: (2015)

CD8(+) T cells regulate tumor ferroptosis during cancer immunotherapy
por: Wang, Weimin, et al.
Publicado: (2019)

The E3 ubiquitin-protein ligase MDM2 is a novel interactor of the von Hippel–Lindau tumor suppressor
por: Falconieri, Antonella, et al.
Publicado: (2020)

Ubiquitin ligase DTX3 empowers mutant p53 to promote ovarian cancer development
por: Wang, Shanshan, et al.
Publicado: (2020)

Ubiquitin ligase TRIM71 suppresses ovarian tumorigenesis by degrading mutant p53
por: Chen, Yajie, et al.
Publicado: (2019)

An E3 Ubiquitin Ligase RNF139 Serves as a Tumor-Suppressor in Glioma
por: Chen, Xiaofeng, et al.
Publicado: (2021)

Ubiquitin ligases and beyond
por: Dikic, Ivan, et al.
Publicado: (2012)

MDM2 promotes genome instability by ubiquitinating the transcription factor HBP1
por: Cao, Zhengyi, et al.
Publicado: (2019)

Functional roles of E3 ubiquitin ligases in gastric cancer
por: Wang, Mingliang, et al.
Publicado: (2020)

CRL Ubiquitin Ligases and DNA Damage Response
por: Li, Ju-Mei, et al.
Publicado: (2012)

The p53–Mdm2 interaction and the E3 ligase activity of Mdm2/Mdm4 are conserved from lampreys to humans
por: Coffill, Cynthia R., et al.
Publicado: (2016)

Differential Degradation of TRA2A and PYCR2 Mediated by Ubiquitin E3 Ligase E4B
por: Lu, Yao, et al.
Publicado: (2022)

The degradation of p53 and its major E3 ligase Mdm2 is differentially dependent on the proteasomal ubiquitin receptor S5a
por: Sparks, A, et al.
Publicado: (2014)

Cardiac-specific ablation of the E3 ubiquitin ligase Mdm2 leads to oxidative stress, broad mitochondrial deficiency and early death
por: Hauck, Ludger, et al.
Publicado: (2017)

Mdm2 enhances ligase activity of parkin and facilitates mitophagy
por: Kook, Seunghyi, et al.
Publicado: (2020)

Ubiquitin ligase RNF125 targets PD-L1 for ubiquitination and degradation
por: Wei, Meng, et al.
Publicado: (2022)

Structural insights into the TRIM family of ubiquitin E3 ligases
por: Li, Yang, et al.
Publicado: (2014)

An ORFeome of rice E3 ubiquitin ligases for global analysis of the ubiquitination interactome
por: Wang, Ruyi, et al.
Publicado: (2022)

Ubiquitin Ligases in Cholesterol Metabolism
por: Jiang, Wei, et al.
Publicado: (2014)

HERC Ubiquitin Ligases in Cancer
por: Sala-Gaston, Joan, et al.
Publicado: (2020)

Th17 cells have stem cell-like features and promote long-term immunity
por: Wei, Shuang, et al.
Publicado: (2012)

E2F1-Dependent Oncogenic Addiction of Melanoma Cells to MDM2
por: Verhaegen, Monique, et al.
Publicado: (2011)

E3 ubiquitin ligase NEDD4L negatively regulates inflammation by promoting ubiquitination of MEKK2
por: Li, Hui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kv30uqmgj95j4tcffmk5j1fe6i